Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer.
about
Adaptive responses of androgen receptor signaling in castration-resistant prostate cancerTargeting the adaptive molecular landscape of castration-resistant prostate cancerERK-mediated NF-κB activation through ASIC1 in response to acidosisMiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators.miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.Androgen pathway resistance in prostate cancer and therapeutic implicationsROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer.AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer.Androgen Receptor Coactivators in Regulation of Growth and Differentiation in Prostate Cancer.Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism.Castration Resistance in Prostate Cancer Is Mediated by the Kinase NEK6.Role of steroid receptor and coregulator mutations in hormone-dependent cancers.Progress in the mechanism and drug development of castration-resistant prostate cancer.Hormone dependent uterine epithelial-stromal communication for pregnancy support.NCOA2 is a candidate target gene of 8q gain associated with clinically aggressive prostate cancer.Thy-1+ Cancer-associated Fibroblasts Adversely Impact Lung Cancer Prognosis.SHP2 negatively regulates HLA-ABC and PD-L1 expression via STAT1 phosphorylation in prostate cancer cells.Glucocorticoid-induced phosphorylation by CDK9 modulates the coactivator functions of transcriptional cofactor GRIP1 in macrophages.CSL regulates AKT to mediate androgen independence in prostate cancer progression.Inhibition of prostate cancer DU145 cell growth with small interfering RNA targeting the SATB1 gene.
P2860
Q26795625-7E9739F7-FE8C-47C1-A4EA-6E4F6272F301Q27022821-364C0882-E289-4A13-A874-7B20C523870FQ28818786-D3CF96DE-9E21-4C2F-8F44-922624CBEB24Q34497810-866BBCEC-75BB-4FCC-9C04-C4F1042466A0Q35897588-570DC246-E1EE-4C55-8D2F-45C4C7A57489Q36416370-EAF6C8A0-B121-4D75-89B9-9AC1E5252C98Q37270422-8FB2040D-6D0D-4760-9AB8-5F979AD0BB00Q37730639-5CA53DCB-3DF5-4E15-BA0B-7BBA5C32874DQ37737611-20919C99-33F2-4D83-BA92-39B12069F27CQ38552283-9C99AC3E-B0DD-4DDE-8E8B-F5F819822E16Q38662384-26D1AA81-817A-48ED-9887-4D172AC9AC88Q38728375-AE17B858-8C21-4641-875D-25A8003738E5Q38736287-09D7713F-4F2B-4C68-BDF4-AD315A3467B4Q38826609-20E262F2-C7E2-4806-BA21-446EB92FB32FQ39439791-527102DF-9B97-42AD-89BE-1540E5CD96F1Q40073572-D5BC1C18-BFEB-4B6D-A203-B506659FC232Q41125664-E426809C-E913-4A49-94A1-6E60ACF3B9A9Q41593253-F7D0F3AC-BF03-4F6D-BAF4-8C3806215A4FQ47144286-5F3C7386-7989-4840-9222-6F1D2B2B37F1Q50927842-8EF2C212-4843-4C80-957F-048FED2B8EFBQ54093494-80D0BBC8-5677-4B3B-B76C-3C7F2BE95A36
P2860
Androgen deprivation-induced NCoA2 promotes metastatic and castration-resistant prostate cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Androgen deprivation-induced N ...... ion-resistant prostate cancer.
@ast
Androgen deprivation-induced N ...... ion-resistant prostate cancer.
@en
type
label
Androgen deprivation-induced N ...... ion-resistant prostate cancer.
@ast
Androgen deprivation-induced N ...... ion-resistant prostate cancer.
@en
prefLabel
Androgen deprivation-induced N ...... ion-resistant prostate cancer.
@ast
Androgen deprivation-induced N ...... ion-resistant prostate cancer.
@en
P2093
P2860
P50
P356
P1476
Androgen deprivation-induced N ...... tion-resistant prostate cancer
@en
P2093
Chad J Creighton
Hui-Ju Lee
Ming-Jer Tsai
Rainer B Lanz
Shih-Chieh Lin
Sophia Y Tsai
P2860
P304
P356
10.1172/JCI76412
P407
P577
2014-10-08T00:00:00Z